Section Arrow
NEO.NASDAQ
- NeoGenomics
Quotes are at least 15-min delayed:2025/07/03 01:50 EDT
Last
 7.4
-0.01 (-0.13%)
Day High 
7.53 
Prev. Close
7.41 
1-M High
8.07 
Volume 
1.18M 
Bid
7.2
Ask
7.7
Day Low
7.32 
Open
7.46 
1-M Low
6.84 
Market Cap 
953.63M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 7.14 
20-SMA 7.3 
50-SMA 7.78 
52-W High 19.115 
52-W Low 6.08 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.61/-0.61
Enterprise Value
1.35B
Balance Sheet
Book Value Per Share
6.90
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
660.57M
Operating Revenue Per Share
4.47
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NEOGNeogen Corp5.23+0.15+2.95%879PE
BIAFbioAffinity Technologies0.29+0.0265+10.06%-- 
DHRDanaher Corp202.5+1.4+0.70%38.97PE
OPKOPKO Health1.34+0.01+0.75%-- 
TMOThermo Fisher Scientific427.76+6.29+1.49%24.72PE
Quotes are at least 15-min delayed:2025/07/03 01:50 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.